INNOVATE BIOPHARMACEUTICALS Chief Medical Officer Patrick FACP receives $1.0M in 2019

INNOVATE BIOPHARMACEUTICALS reports 2019 executive compensation

By ExecPay News

Published: January 22, 2020

INNOVATE BIOPHARMACEUTICALS reported fiscal year 2019 executive compensation information on January 22, 2020.
In 2019, four executives at INNOVATE BIOPHARMACEUTICALS received on average a compensation package of $551K, a 17% decrease compared to previous year.
Average pay of disclosed executives at INNOVATE BIOPHARMACEUTICALS
Patrick Griffin, M.D., F.A.C.P, Chief Medical Officer, received $1M in total. 43.33% of FACP's compensation, or $448.4K, was in option awards. FACP also received $75K in bonus, $328.1K in salary, as well as $183.4K in stock awards.
Sandeep Laumas, Chairman, received a compensation package of $475.2K, which decreased by 31% compared to previous year. 57.88% of the compensation package, or $275K, was in salary.
Jay P. Madan, President and Chief Business Officer, earned $385.1K in 2019, a 44% decrease compared to previous year.
Christopher Prior, Chief Executive Officer, received $308.7K in 2019, which decreases by 49% compared to 2018.

Related executives

Sandeep Laumas

INNOVATE BIOPHARMACEUTICALS

Chairman

Christopher Prior

INNOVATE BIOPHARMACEUTICALS

Chief Executive Officer

Jay Madan

INNOVATE BIOPHARMACEUTICALS

President and Chief Business Officer

Patrick FACP

INNOVATE BIOPHARMACEUTICALS

Chief Medical Officer

You may also like

Source: SEC filing on January 22, 2020.